FREMONT, CA--(Marketwired - July 27, 2016) - Lam Research Corp. (
Highlights for the June 2016 quarter were as follows:
- Shipments of $1,587 million and revenue of $1,546 million.
- GAAP gross margin of 45.2%, GAAP operating margin of 20.0%, and GAAP diluted EPS of $1.46.
- Non-GAAP gross margin of 46.6%, non-GAAP operating margin of 23.2%, and non-GAAP diluted EPS of $1.80.
Key Financial Data for the Quarters Ended June 26, 2016 and March 27, 2016 | ||||||||||
(in thousands, except per-share data, percentages, and basis points) | ||||||||||
U.S. GAAP | ||||||||||
June 2016 | March 2016 | Change Q/Q | ||||||||
Shipments | $ | 1,587,417 | $ | 1,446,002 | + 10% | |||||
Revenue | $ | 1,546,261 | $ | 1,314,055 | + 18% | |||||
Gross margin as percentage of revenue | 45.2 | % | 43.5 | % | + 170 bps | |||||
Operating margin as percentage of revenue | 20.0 | % | 14.5 | % | + 550 bps | |||||
Diluted EPS | $ | 1.46 | $ | 0.82 | + 78% | |||||
Non-GAAP | ||||||||||
June 2016 | March 2016 | Change Q/Q | ||||||||
Shipments | $ | 1,587,417 | $ | 1,446,002 | + 10% | |||||
Revenue | $ | 1,546,261 | $ | 1,314,055 | + 18% | |||||
Gross margin as percentage of revenue | 46.6 | % | 45.1 | % | + 150 bps | |||||
Operating margin as percentage of revenue | 23.2 | % | 18.4 | % | + 480 bps | |||||
Diluted EPS | $ | 1.80 | $ | 1.18 | + 53% | |||||
U.S. GAAP Financial Results
For the June 2016 quarter, revenue was $1,546 million, gross margin was $699 million, or 45.2% of revenue, operating expenses were $390 million, operating margin was 20.0% of revenue, and net income was $259 million, or $1.46 per diluted share on a GAAP basis. This compares to revenue of $1,314 million, gross margin of $571 million, or 43.5% of revenue, operating expenses of $381 million, operating margin of 14.5% of revenue, and net income of $143 million, or $0.82 per diluted share, for the quarter ended March 27, 2016 (the "March 2016 quarter").
Non-GAAP Financial Results
For the June 2016 quarter, non-GAAP gross margin was $720 million or 46.6% of revenue, non-GAAP operating expenses were $361 million, non-GAAP operating margin was 23.2% of revenue, and non-GAAP net income was $315 million, or $1.80 per diluted share. This compares to non-GAAP gross margin of $593 million or 45.1% of revenue, non-GAAP operating expenses of $350 million, non-GAAP operating margin of 18.4% of revenue, and non-GAAP net income of $203 million, or $1.18 per diluted share for the March 2016 quarter.
"The June quarter was characterized by very positive momentum as the Company met or exceeded expectations across the board," said Martin Anstice, Lam Research's President and Chief Executive Officer. "Sequential quarterly operating profit growth of approximately 500 basis points is a strong endorsement of Lam's opportunity and execution capabilities. Our guidance for record shipments in September and outlook for second half 2016 growth confirms our increased strategic relevance, strong customer trust and the differentiation of our core values. We believe that our underlying fundamentals and multi-year outperformance opportunity remain strong on a standalone basis, and subsequent to closing our merger with KLA-Tencor we are focused on further strengthening that position and accelerating innovation for the benefit of our customers."
Balance Sheet and Cash Flow Results
Cash and cash equivalents, short-term investments, and restricted cash and investments balances increased to $7.1 billion at the end of the June 2016 quarter compared to $4.8 billion at the end of the March 2016 quarter. This increase was primarily the result of approximately $1.9 billion in debt proceeds, net repayments of maturing debt, combined with $424 million of cash generated in operating activities.
Deferred revenue at the end of the June 2016 quarter increased to $566 million as compared to $511 million at the end of the March 2016 quarter. Deferred profit at the end of the June 2016 quarter increased to $349 million as compared to $334 million at the end of the March 2016 quarter. Lam's deferred revenue balance does not include shipments to Japanese customers, to whom title does not transfer until customer acceptance. Shipments to Japanese customers are classified as inventory at cost until the time of acceptance. The estimated future revenue from shipments to Japanese customers was approximately $132 million as of June 26, 2016.
Geographic Distribution
The geographic distribution of shipments and revenue during the June 2016 quarter is shown in the following table:
Region | Shipments | Revenue | |||
China | 17 | % | 22 | % | |
Southeast Asia | 20 | % | 21 | % | |
Taiwan | 20 | % | 15 | % | |
Korea | 15 | % | 15 | % | |
Japan | 14 | % | 14 | % | |
United States | 10 | % | 10 | % | |
Europe | 4 | % | 3 | % | |
Outlook
For the September 2016 quarter, Lam is providing the following guidance:
U.S. GAAP | Reconciling Items | Non-GAAP | |||||||
Shipments | $1.700 Billion | +/- | $75 Million | -- | $1.700 Billion | +/- | $75 Million | ||
Revenue | $1.625 Billion | +/- | $75 Million | -- | $1.625 Billion | +/- | $75 Million | ||
Gross margin | 44.2% | +/- | 1% | $21 Million | 45.5% | +/- | 1% | ||
Operating margin | 20.2% | +/- | 1% | $37 Million | 22.5% | +/- | 1% | ||
Net income per diluted share | $1.48 | +/- | $0.10 | $48 Million | $1.77 | +/- | $0.10 | ||
Diluted share count | 178 Million | 2 Million | 176 million | ||||||
The information provided above is only an estimate of what the Company believes is realizable as of the date of this release, and does not incorporate the potential impact of any KLA-Tencor related acquisition or integration expenses other than the net interest expense associated with the KLA-Tencor pre-acquisition funding, business combinations, asset acquisitions, divestitures, financing arrangements, other investments, or other significant transactions that may be completed after the date of this release. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:
- Gross Margin - amortization related to intangible assets acquired in the Novellus transaction, $21 million.
- Operating margin - amortization related to intangible assets acquired in the Novellus transaction, $37 million.
- Earnings per share - amortization related to intangible assets acquired in the Novellus transaction, $37 million; net interest expense associated with KLA-Tencor pre-acquisition funding, $18 million; amortization of note discounts, $6 million; and associated tax benefit for non-GAAP items ($13) million; totaling $48 million.
- Diluted share count - impact of a note hedge issued contemporaneously with the convertible notes due 2018, 2 million shares.
Use of Non-GAAP Financial Results
In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company's non-GAAP results for both the June 2016 and March 2016 quarters exclude amortization related to intangible assets acquired in the Novellus transaction, restructuring impacts, the amortization of notes discounts, costs associated with the KLA-Tencor acquisition, amortization of bridge loan issuance costs and other related fees associated with the KLA-Tencor acquisition, tax benefit of non-GAAP items, and income tax benefit on resolution of certain tax matters. Additionally, the June 2016 quarter excludes Novellus acquisition transaction related inventory fair value impact, cost associated with campus consolidation, gain on sale of real property net of associated exit costs, KLA-Tencor pre-acquisition funding net interest expense, and change to income tax benefit from court ruling.
Management uses non-GAAP gross margin, operating income, operating expenses, operating margin, net income, and net income per diluted share to evaluate the Company's operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors' ability to view the Company's results from management's perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company's website at http://investor.lamresearch.com.
Caution Regarding Forward-Looking Statements
Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to; the estimated future revenue from shipments to Japanese customers; our second half calendar year 2016 growth outlook and its impact on our strategic relevance, customer trust and differentiation of our core values; the extent of our underlying fundamentals and multi-year outperformance opportunities as a standalone entity and our ability to strengthen those positions and accelerate innovation for the benefit of our customers following the proposed acquisition of KLA-Tencor Corporation ("KLA-Tencor"); the legal and business factors that may affect our future tax rate; our ability to close the proposed acquisition of KLA-Tencor; and our guidance for shipments, revenue, gross margin, operating margin, net income or earnings per diluted share, and diluted share count. Some factors that may affect these forward-looking statements include: the proposed transaction with KLA-Tencor may not close and if it does close we may not receive the expected benefits of the proposed transaction, such as the scale and breadth of critical technologies and better financial performance for our stockholders; business conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; and the actions of our customers and competitors may be inconsistent with our expectations, as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our annual report on Form 10-K for the fiscal year ended June 28, 2015 and quarterly reports on Form 10-Q for the fiscal quarters ended September 27, 2015, December 27, 2015 and March 27, 2016. These uncertainties and changes could materially affect the forward looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.
About Lam Research
Lam Research Corp. (
Consolidated Financial Tables Follow.
LAM RESEARCH CORPORATION | |||||||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | |||||||||||||||||||||
(in thousands, except per share data and percentages) | |||||||||||||||||||||
Three Months Ended | Twelve Months Ended | ||||||||||||||||||||
June 26, 2016 | March 27, 2016 | June 28, 2015 | June 26, 2016 | June 28, 2015 | |||||||||||||||||
(unaudited) | (unaudited) | (unaudited) | (unaudited) | (1) | |||||||||||||||||
Revenue | $ | 1,546,261 | $ | 1,314,055 | $ | 1,481,370 | $ | 5,885,893 | $ | 5,259,312 | |||||||||||
Cost of goods sold | 847,477 | 742,790 | 839,832 | 3,266,971 | 2,974,976 | ||||||||||||||||
Gross margin | 698,784 | 571,265 | 641,538 | 2,618,922 | 2,284,336 | ||||||||||||||||
Gross margin as a percent of revenue | 45.2 | % | 43.5 | % | 43.3 | % | 44.5 | % | 43.4 | % | |||||||||||
Research and development | 237,255 | 221,494 | 221,675 | 913,712 | 825,242 | ||||||||||||||||
Selling, general and administrative | 152,288 | 159,018 | 149,384 | 630,954 | 591,611 | ||||||||||||||||
Goodwill Impairment | -- | -- | 79,444 | -- | 79,444 | ||||||||||||||||
Total operating expenses | 389,543 | 380,512 | 450,503 | 1,544,666 | 1,496,297 | ||||||||||||||||
Operating income | 309,241 | 190,753 | 191,035 | 1,074,256 | 788,039 | ||||||||||||||||
Operating income as a percent of revenue | 20.0 | % | 14.5 | % | 12.9 | % | 18.3 | % | 15.0 | % | |||||||||||
Other expense, net | (27,249 | ) | (29,834 | ) | (20,353 | ) | (114,139 | ) | (47,189 | ) | |||||||||||
Income before income taxes | 281,992 | 160,919 | 170,682 | 960,117 | 740,850 | ||||||||||||||||
Income tax expense | (23,053 | ) | (17,468 | ) | (39,411 | ) | (46,068 | ) | (85,273 | ) | |||||||||||
Net income | $ | 258,939 | $ | 143,451 | $ | 131,271 | $ | 914,049 | $ | 655,577 | |||||||||||
Net income per share: | |||||||||||||||||||||
Basic | $ | 1.62 | $ | 0.90 | $ | 0.83 | $ | 5.75 | $ | 4.11 | |||||||||||
Diluted | $ | 1.46 | $ | 0.82 | $ | 0.74 | $ | 5.22 | $ | 3.70 | |||||||||||
Number of shares used in per share calculations: | |||||||||||||||||||||
Basic | 159,862 | 159,039 | 158,590 | 158,919 | 159,629 | ||||||||||||||||
Diluted | 177,649 | 174,373 | 176,575 | 175,159 | 177,067 | ||||||||||||||||
Cash dividend declared per common share | $ | 0.30 | $ | 0.30 | $ | 0.30 | $ | 1.20 | $ | 0.84 | |||||||||||
(1) Derived from audited financial statements. | |||||||||||||||||||||
LAM RESEARCH CORPORATION | |||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||||||
(in thousands) | |||||||||||
June 26, 2016 | March 27, 2016 | June 28, 2015 | |||||||||
(unaudited) | (unaudited) | (1) | |||||||||
ASSETS | |||||||||||
Cash and cash equivalents | $ | 5,039,322 | $ | 2,232,021 | $ | 1,501,539 | |||||
Investments | 1,788,612 | 2,306,718 | 2,574,947 | ||||||||
Accounts receivable, net | 1,262,145 | 1,236,617 | 1,093,582 | ||||||||
Inventories | 971,911 | 934,932 | 943,346 | ||||||||
Other current assets | 152,921 | 231,277 | 157,435 | ||||||||
Total current assets | 9,214,911 | 6,941,565 | 6,270,849 | ||||||||
Property and equipment, net | 639,608 | 664,424 | 621,418 | ||||||||
Restricted cash and investments | 250,421 | 227,838 | 170,969 | ||||||||
Goodwill and intangible assets | 1,951,197 | 1,999,338 | 2,115,649 | ||||||||
Other assets | 215,391 | 191,097 | 185,763 | ||||||||
Total assets | $ | 12,271,528 | $ | 10,024,262 | $ | 9,364,648 | |||||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||
Current portion of convertible notes and capital leases | $ | 949,494 | $ | 978,982 | $ | 1,359,650 | |||||
Other current liabilities | 1,470,308 | 1,363,204 | 1,271,711 | ||||||||
Total current liabilities | 2,419,802 | 2,342,186 | 2,631,361 | ||||||||
Long-term debt and capital leases | 3,383,581 | 1,407,250 | 1,001,382 | ||||||||
Income taxes payable | 231,514 | 266,681 | 202,930 | ||||||||
Other long-term liabilities | 134,562 | 137,017 | 184,023 | ||||||||
Total liabilities | 6,169,459 | 4,153,134 | 4,019,696 | ||||||||
Temporary equity, convertible notes | 207,552 | 178,789 | 241,808 | ||||||||
Stockholders' equity (2) | 5,894,517 | 5,692,339 | 5,103,144 | ||||||||
Total liabilities and stockholders' equity | $ | 12,271,528 | $ | 10,024,262 | $ | 9,364,648 | |||||
(1) Derived from audited financial statements. | |||||||||||
(2) Common shares issued and outstanding were 160,201 as of June 26, 2016, 159,319 as of March 27, 2016 and 158,531 as of June 28, 2015. | |||||||||||
LAM RESEARCH CORPORATION | |||||||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||||||||||||||||
(in thousands) | |||||||||||||||||||||
Three Months Ended | Twelve Months Ended | ||||||||||||||||||||
June 26, 2016 | March 27, 2016 | June 28, 2015 | June 26, 2016 | June 28, 2015 | |||||||||||||||||
(unaudited) | (unaudited) | (unaudited) | (unaudited) | (1) | |||||||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||||||||||||
Net income | $ | 258,939 | $ | 143,451 | $ | 131,271 | $ | 914,049 | $ | 655,577 | |||||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||||||||
Depreciation and amortization | 74,976 | 73,664 | 70,177 | 291,028 | 277,920 | ||||||||||||||||
Deferred income taxes | (46,708 | ) | (4,908 | ) | (2,694 | ) | (49,003 | ) | 5,551 | ||||||||||||
Impairment of long-lived assets | -- | -- | 9,821 | -- | 9,821 | ||||||||||||||||
Equity-based compensation expense | 39,288 | 34,716 | 39,734 | 142,348 | 135,354 | ||||||||||||||||
Income tax benefit on equity-based compensation plans | (8,048 | ) | 1,312 | (2,124 | ) | (1,023 | ) | 11,316 | |||||||||||||
Excess tax benefit on equity-based compensation plans | 9,035 | (2,262 | ) | 1,809 | 1,020 | (11,398 | ) | ||||||||||||||
Amortization of note discounts and issuance costs | 14,584 | 22,458 | 11,023 | 70,522 | 37,550 | ||||||||||||||||
Gain on sale of business | -- | -- | -- | -- | (7,431 | ) | |||||||||||||||
Gain on sale of assets | (15,223 | ) | -- | -- | (15,223 | ) | -- | ||||||||||||||
Goodwill impairment | -- | -- | 79,444 | -- | 79,444 | ||||||||||||||||
Other, net | 17,929 | 10,256 | 3,621 | 48,788 | 12,656 | ||||||||||||||||
Changes in operating assets and liabilities | 79,052 | (95,776 | ) | (50,016 | ) | (52,229 | ) | (420,857 | ) | ||||||||||||
Net cash provided by operating activities | 423,824 | 182,911 | 292,066 | 1,350,277 | 785,503 | ||||||||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||||||||||||||||
Capital expenditures and intangible assets | (51,726 | ) | (46,007 | ) | (63,133 | ) | (175,330 | ) | (198,265 | ) | |||||||||||
Business acquisitions, net of cash acquired | -- | -- | -- | -- | (1,137 | ) | |||||||||||||||
Net sale (purchase) of available-for-sale securities | 605,891 | 181,938 | (278,379 | ) | 798,828 | (949,740 | ) | ||||||||||||||
Proceeds from sale of business | — | -- | -- | -- | 41,212 | ||||||||||||||||
Proceeds from sale of assets | 79,730 | -- | -- | 79,730 | 3,978 | ||||||||||||||||
Transfers of restricted cash and investments | (112,381 | ) | -- | 1,056 | (112,381 | ) | 356 | ||||||||||||||
Other, net | -- | (200 | ) | -- | 1,636 | (2,500 | ) | ||||||||||||||
Net cash provided by (used for) investing activities | 521,514 | 135,731 | (340,456 | ) | 592,483 | (1,106,096 | ) | ||||||||||||||
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||||||||||||||
Principal payments on long-term debt and capital lease obligations | (450,624 | ) | (107 | ) | (615 | ) | (451,497 | ) | (1,515 | ) | |||||||||||
Proceeds from issuance of long-term debt, net of issuance costs | 2,374,220 | (8,372 | ) | 345 | 2,338,144 | 992,225 | |||||||||||||||
Excess tax benefit on equity-based compensation plans | (9,035 | ) | 2,262 | (1,809 | ) | (1,020 | ) | 11,398 | |||||||||||||
Treasury stock purchases | (27,114 | ) | (20,092 | ) | (74,339 | ) | (158,389 | ) | (573,240 | ) | |||||||||||
Dividends paid | (47,308 | ) | (47,539 | ) | (28,714 | ) | (190,402 | ) | (116,059 | ) | |||||||||||
Re-issuance of treasury stock related to employee stock purchase plan | 20,360 | 16,387 | 16,950 | 55,992 | 48,803 | ||||||||||||||||
Proceeds from issuance of common stock | 1,547 | 308 | 1,285 | 3,405 | 17,520 | ||||||||||||||||
Other, net | (159 | ) | (7 | ) | (660 | ) | (488 | ) | (660 | ) | |||||||||||
Net cash provided by (used for) financing activities | 1,861,887 | (57,160 | ) | (87,557 | ) | 1,595,745 | 378,472 | ||||||||||||||
Effect of exchange rate changes on cash and cash equivalents | 76 | 2,666 | 1,850 | (722 | ) | (9,017 | ) | ||||||||||||||
Net increase (decrease) in cash and cash equivalents | 2,807,301 | 264,148 | (134,097 | ) | 3,537,783 | 48,862 | |||||||||||||||
Cash and cash equivalents at beginning of period | 2,232,021 | 1,967,873 | 1,635,636 | 1,501,539 | 1,452,677 | ||||||||||||||||
Cash and cash equivalents at end of period | $ | 5,039,322 | $ | 2,232,021 | $ | 1,501,539 | $ | 5,039,322 | $ | 1,501,539 | |||||||||||
(1) Derived from audited financial statements. | |||||||||||||||||||||
Non-GAAP Financial Summary | ||||||||
(in thousands, except percentages and per share data) | ||||||||
(unaudited) | ||||||||
Three Months Ended | ||||||||
June 26, 2016 | March 27, 2016 | |||||||
Revenue | $ | 1,546,261 | $ | 1,314,055 | ||||
Gross margin | $ | 720,162 | $ | 592,515 | ||||
Gross margin as percentage of revenue | 46.6 | % | 45.1 | % | ||||
Operating expenses | $ | 361,490 | $ | 350,235 | ||||
Operating income | $ | 358,672 | $ | 242,280 | ||||
Operating margin as a percentage of revenue | 23.2 | % | 18.4 | % | ||||
Net income | $ | 314,806 | $ | 202,821 | ||||
Net income per diluted share | $ | 1.80 | $ | 1.18 | ||||
Shares used in per share calculation - diluted | 175,052 | 172,153 | ||||||
Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income and U.S. GAAP number of dilutive shares to Non-GAAP number of dilutive shares | |||||||||
(in thousands, except per share data) | |||||||||
(unaudited) | |||||||||
Three Months Ended | |||||||||
June 26, 2016 | March 27, 2016 | ||||||||
U.S. GAAP net income | $ | 258,939 | $ | 143,451 | |||||
Pre-tax non-GAAP items: | |||||||||
Amortization related to intangible assets acquired in Novellus transaction - cost of goods sold | 21,250 | 21,250 | |||||||
Novellus acquisition-related inventory fair value impact - cost of goods sold | 128 | -- | |||||||
Restructuring charges - research and development | 43 | 72 | |||||||
Cost associated with campus consolidation - research and development | 7,763 | -- | |||||||
KLA-Tencor acquisition-related costs - selling, general and administrative | 19,270 | 14,323 | |||||||
Gain on sale of assets, net associated exit costs - selling, general and administrative | (15,223 | ) | -- | ||||||
Amortization related to intangible assets acquired in Novellus transaction -selling, general and administrative | 16,083 | 16,084 | |||||||
Restructuring charges (benefit) - selling, general and administrative | 117 | (202 | ) | ||||||
Amortization of note discounts - other expense, net | 7,492 | 9,333 | |||||||
Amortization of bridge loan issuance costs and other related fees - other expense, net | 6,938 | 13,332 | |||||||
KLA-Tencor pre-acquisition funding interest expense, net - other expense, net | 3,821 | -- | |||||||
Net income tax benefit on non-GAAP items | (8,413 | ) | (14,320 | ) | |||||
Income tax benefit on resolution of certain tax matters | (2,515 | ) | (502 | ) | |||||
Change to income tax benefit due to a court ruling | (887 | ) | -- | ||||||
Non-GAAP net income | 314,806 | 202,821 | |||||||
Non-GAAP net income per diluted share | $ | 1.80 | $ | 1.18 | |||||
U.S. GAAP number of shares used for per diluted share calculation | 177,649 | 174,373 | |||||||
Effect of convertible note hedge | (2,597 | ) | (2,220 | ) | |||||
Non-GAAP number of shares used for per diluted share calculation | 175,052 | 172,153 | |||||||
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income | |||||||||
(unaudited) | |||||||||
Three Months Ended | |||||||||
June 26, 2016 | March 27, 2016 | ||||||||
U.S. GAAP gross margin | $ | 698,784 | $ | 571,265 | |||||
Pre-tax non-GAAP items: | |||||||||
Amortization related to intangible assets acquired in Novellus transaction | 21,250 | 21,250 | |||||||
Novellus acquisition-related inventory fair value impact | 128 | -- | |||||||
Non-GAAP gross margin | $ | 720,162 | $ | 592,515 | |||||
U.S. GAAP gross margin as a percentage of revenue | 45.2 | % | 43.5 | % | |||||
Non-GAAP gross margin as a percentage of revenue | 46.6 | % | 45.1 | % | |||||
U.S. GAAP operating expenses | $ | 389,543 | $ | 380,512 | |||||
Pre-tax non-GAAP items: | |||||||||
Restructuring charges | (43 | ) | (72 | ) | |||||
Cost associated with campus consolidation | (7,763 | ) | -- | ||||||
KLA-Tencor acquisition-related costs | (19,270 | ) | (14,323 | ) | |||||
Gain on sale of assets, net associated exit costs | 15,223 | -- | |||||||
Amortization related to intangible assets acquired in Novellus transaction | (16,083 | ) | (16,084 | ) | |||||
Restructuring (charges) benefit | (117 | ) | 202 | ||||||
Non-GAAP operating expenses | $ | 361,490 | $ | 350,235 | |||||
Non-GAAP operating income | $ | 358,672 | $ | 242,280 | |||||
GAAP operating margin as percent of revenue | 20.0 | % | 14.5 | % | |||||
Non-GAAP operating margin as a percent of revenue | 23.2 | % | 18.4 | % |
Contact Information:
Lam Research Corporation Contacts:
Satya Kumar
Investor Relations
phone: 510-572-3232
e-mail: satya.kumar@lamresearch.com